CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Stereotactic radiotherapy delivered by CyberKnife +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01290835
NCT01290835N/ACompleted
CompareCT.gov

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

Essentia Health·interventional·Posted Feb 7, 2011·Updated Aug 15, 2025

In Brief

A clinical study evaluating Stereotactic radiotherapy delivered by CyberKnife and stereotactic radiotherapy for Breast Cancer. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if it is feasible, safe, and effective to use Cyberknife radiotherapy to deliver partial breast radiotherapy after lumpectomy.Patients meeting eligibility criteria will be invited to participate. Adjuvant radiotherapy will be delivered using CyberKnife radiotherapy using twice daily sessions for five days for a total of ten sessions. Short-term and long-term toxicity will be assessed as well as Tumor control and site of failure (if any).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 7, 2011
Enrollment StartJun 1, 2010
Primary CompletionAug 1, 2025
TodayJul 2, 2026
Enrollment to primary: 15.2 yearsPosted 15.4 years ago

Interventions

Stereotactic radiotherapy delivered by CyberKniferadiation

Adjuvant radiotherapy will be delivered using CyberKnife radiotherapy using twice daily sessions for five days for a total of ten sessions.

stereotactic radiotherapyradiation